Generate a tailored SOP for Dr. Michael Zelefsky. Improve your application with a focused, well-structured draft.
Michael J. Zelefsky, MD, specializes in Radiation Oncology at NYU Langone Health, where he exists to treat adult patients, primarily focusing on prostate cancer. With over 30 years of experience, Dr. Zelefsky is passionate about the continuous evolution of radiation oncology and its technological advancements, which lead to increased chances of cure and fewer side effects. He has extensive experience in various radiation therapy techniques, notably in intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT). Dr. Zelefsky has played a critical role in developing innovative protocols for brachytherapy and has been recognized for his contributions to the field by receiving the Ulrich Henschke Award from the American Brachytherapy Society. In addition to his clinical work, he actively engages in research, having co-authored more than 350 peer-reviewed articles, significantly changing the way prostate cancer is treated globally. At NYU Langone’s Perlmutter Cancer Center, he utilizes the latest advanced technologies to ensure the best patient outcomes, emphasizing understanding and personalization in treatment. Dr. Zelefsky works closely with multidisciplinary teams and takes great care to explain treatment options thoroughly to his patients, embodying compassionate care in his practice.
NYU Langone Health • New York
Oversees fellowship programs in the Department of Radiation Oncology and contributes to educational and clinical advancements in radiation therapy.
NYU Langone Health • New York
Leads research and clinical implementation of MRI-guided radiation therapy.
Department of Radiation Oncology, NYU Langone Health • New York
Responsible for academic policies and faculty affairs within the department.
Open Program in Biomedical Sciences (Vilcek Institute) covers departments like Biochemistry, Pathology, Neuroscience, Microbiology, etc.